Navigation Links
Cepheid Reports Fourth Quarter and Full Year 2011 Results
Date:1/26/2012

n computing diluted net income (loss) per share

64,11363,37266,75059,712CEPHEIDCONDENSED CONSOLIDATED UNAUDITED BALANCE SHEETS(in thousands)December 31, 2011December 31, 2010ASSETSCurrent assets:Cash and cash equivalents

$
5,008$
79,538Accounts receivable, net

35,37528,010Inventory

62,23937,598Prepaid expenses and other current assets

5,2454,138Total current assets

217,867149,284Property and equipment, net

35,83327,438Other non-current assets

730607Intangible assets, net

13,79524,688Goodwill

18,44518,594Total assets

$
286,670$
220,611LIABILITIES AND SHAREHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
32,167$
21,957Accrued compensation

17,92812,594Accrued royalties

8,3577,994Accrued and other liabilities

3,0861,288Current portion of deferred revenue

8,1768,207Current portion of notes payable

-1,679Total current liabilities

69,71453,719Long-term portion of deferred revenue

2,0034,057Notes payable, less current portion

-4,991Other liabilities

3,1204,182Total liabilities

74,83766,949Shareholders' equity:Common stock

324,211288,387Additional paid-in capital

93,14472,731Accumulated other comprehensive income

33726Accumulated deficit

(205,555)(208,182)Total shareholders' equity

211,833153,662Total liabilities and shareholders' equity

$
286,670$
220,611CEPHEIDCONDENSED CONSOLIDATED UNAUDITED STATEMENTS OF CASH FLOWS(in thousands)Years Ended December 31,20112010Cash flows from operating activities:Net income (loss)

$
2,627$
(5,917)Adjustments to reconcile net income (loss) to net cash used in operating activities:Depreciation and amortization of property and equipment

10,2989,326Amortization of intangible assets

6,5236,966Amortization of terminated patent license

5,372-Stock-based compensation related to em
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cepheid Welcomes Senior Vice President of Human Resources
2. Cepheid Receives FDA Clearance for Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
3. Cepheid Schedules 2010 Third Quarter Financial Results Announcement and Webcast
4. Cepheid to Webcast Upcoming Financial Presentations
5. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
6. Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast
7. Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast
8. Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
9. Cepheid Reports 2009 First Quarter Results
10. Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
11. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... NEW YORK , June 1, 2015 /PRNewswire/ ... medical researcher  Eliseo Oreste Salinas , MD, MSc, ... and development. Dr. Salinas, who holds ... in pharmacology, brings a record of significant accomplishments ... in psychiatry.  Dr. Salinas has played ...
(Date:6/1/2015)... South Korea , June 1, 2015 ... Cross Biotherapeutics Inc. (GCBT) kicked off construction today on ... Montreal Technoparc,s Saint-Laurent Campus. The CA$315 million project represents ... Canada in the biopharmaceutical industry, ... immunoglobulin (IVIG) and albumin manufacturing plant in ...
(Date:6/1/2015)... 1, 2015 GenomeDx Biosciences today ... platform, successfully classified various subtypes of bladder ... certain biomarkers, including one type associated with ... genomic signature has potential as a tool ... in patients with muscle-invasive bladder cancers (MIBC). ...
(Date:6/1/2015)... Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for ... first quarter financial statements and MD&A have been filed on SEDAR ... 31,(in CDN$,000 except per share data) , 2015 , ... profit , 1,531 , 329 Ebitda* , ... , (531) Basic earnings (loss) per share ...
Breaking Biology Technology:Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3
... HILL, N.C., May 22 Pharmaceutical and biotech,companies increasingly ... (QA) functions. This benchmarking study will help R&D,Quality Assurance ... limited QA staff resources so that they have the ... services in regards to the FDA,s Risk-Bases method for ...
... BioElectronics President, CEO, and Chairman recaps recent investor ... ... May 22 Andrew Whelan,President and CEO of BioElectronics Corporation ... patch,with an embedded battery operated microchip that delivers pulsed,electromagnetic therapy, ...
... to Board, DUBLIN, May 22 Amarin Corporation ... closed the $30 million first,tranche of its previously announced ... tranche, after deducting the placement agents, fees,and estimated offering ... with the financing, Amarin has appointed to its Board,representatives ...
Cached Biology Technology:Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry 2BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 2BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 3BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 4BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 5BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 6BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 7BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 8Amarin Announces Completion of the First Tranche of $60 Million Private Placement 2Amarin Announces Completion of the First Tranche of $60 Million Private Placement 3Amarin Announces Completion of the First Tranche of $60 Million Private Placement 4Amarin Announces Completion of the First Tranche of $60 Million Private Placement 5
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/11/2015)... 2015  Through a well-rounded UAS delegation representing private industry, ... strong showing at AUVSI,s Unmanned 2015 conference last week in ... Ohio,s UAS industry met with over 200 hundred ... along the UAS ecosystem. "Our message is ... for Aerospace Rich Knoll . "If you want to ...
(Date:5/6/2015)... AVIV, Israel , May 6, 2015 ... world,s most established helmet producer, announced today that they ... Smart Helmet, the world,s first bio-sensing cycling helmet and ... be released in two new colors in order to ... for the product. In addition, LifeBEAM and Lazer announced ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... Understanding whether inbreeding accounts for early mortality is a ... Bekaa, Lebanon, in which the marriage rate among first ... new study appearing in the October issue of Current ... mortality is not closely related parents though this ...
... areas seem to have a marked advantage over their rural ... much larger range of conditions. In fact, new research ... many urban bird species means they don,t just survive but ... very challenging environment. "The urban habitat is usually more ...
... -- Topics include: discovery of exceptionally preserved soft-bodied ... arctic lake containing sediments 200,000 years old; effects of ... northern Guatemala; a new catalog of episodic tremor and ... model of Sierra Nevada volcanism and uplift. The GSA ...
Cached Biology News:'Kissing cousins' 2City birds better than rural species in coping with human disruption 2October Geology and GSA Today media highlights 2October Geology and GSA Today media highlights 3October Geology and GSA Today media highlights 4October Geology and GSA Today media highlights 5October Geology and GSA Today media highlights 6October Geology and GSA Today media highlights 7October Geology and GSA Today media highlights 8October Geology and GSA Today media highlights 9October Geology and GSA Today media highlights 10October Geology and GSA Today media highlights 11
... calcium binding proteins such as calmodulin and troponin ... and beta chain whereas S100B is composed of ... expressed in the antigen presenting cells such as ... cells in the paracortex of lymph nodes. ...
LEAF™ Purified anti-human/mouse/rat ICOS...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Purified anti-eIF-4E...
Biology Products: